Detalhe da pesquisa
1.
Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma.
Blood
; 140(25): 2697-2708, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700381
2.
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma.
Blood
; 140(19): 2024-2036, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35914220
3.
Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma.
Haematologica
; 109(2): 533-542, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470137
4.
Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy.
J Natl Compr Canc Netw
; 21(4): 373-382.e1, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015335
5.
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
Blood
; 132(10): 1013-1021, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049811
6.
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703).
Biol Blood Marrow Transplant
; 24(4): 700-707, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29289757
7.
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.
Blood
; 127(24): 2980-90, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118452
8.
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.
Am J Hematol
; 93(4): 486-493, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266344
9.
Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.
Biol Blood Marrow Transplant
; 23(6): 922-929, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28267593
10.
Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab.
Biol Blood Marrow Transplant
; 23(11): 1861-1869, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28733266
11.
Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 20(8): 1183-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24769014
12.
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
Br J Haematol
; 165(4): 510-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24579926
13.
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.
Blood
; 119(18): 4129-32, 2012 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22343727
14.
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study.
Leuk Lymphoma
; : 1-9, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629176
15.
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.
Biol Blood Marrow Transplant
; 18(3): 486-92, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22198542
16.
PD-1 Blockade After Avelumab in Relapsed/Refractory Classical Hodgkin Lymphoma.
Clin Lymphoma Myeloma Leuk
; 22(10): e893-e897, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778267
17.
Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b Study.
Clin Lymphoma Myeloma Leuk
; 22(7): e443-e451, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031227
18.
Peripheral T-cell lymphoma: a case-based discussion of recent advances in patient management.
Clin Adv Hematol Oncol
; 9(4 Suppl 9): 1-16, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21559001
19.
CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma.
Blood Adv
; 5(20): 4059-4063, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34492703
20.
Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 20(11): 749-756.e1, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32800518